Germline pathogenic variants and somatic mutations in the BAP1 gene have been described in ocular and cutaneous melanoma and paralleled with a highly aggressive ocular melanoma phenotype [56,57] but also detected in several other cancer subtypes [58]. This evidence concerns the gene BAP1 and cancer.